Literature DB >> 16552592

[Targeted cardiovascular therapy: shock treatment in ambulance, emergency room and intensive care unit].

S Kluge1, G Kreymann.   

Abstract

Since the prognosis for all forms of shock essentially depends on immediate and effective therapy, early diagnosis and determination of the underlying cause are of central importance to the disease course. Except for cardiogenic shock, all forms of shock require early and adequate fluid substitution. It has previously been shown that septic shock treatment guided by central venous oxygen saturation may lead to a reduction in mortality in patients with septic shock. Similar therapeutic strategies are currently being developed for the more invasive monitoring procedures used in intensive care, but their effectiveness has to yet to be proven. Novel therapeutic approaches for the treatment of septic shock include improved adjunctive sepsis therapy and the use of vasopressin. However, the effectiveness of the latter treatment option cannot yet be conclusively assessed.

Entities:  

Mesh:

Year:  2006        PMID: 16552592     DOI: 10.1007/s00108-006-1587-x

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  24 in total

Review 1.  Diagnosis and management of aortic dissection.

Authors:  R Erbel; F Alfonso; C Boileau; O Dirsch; B Eber; A Haverich; H Rakowski; J Struyven; K Radegran; U Sechtem; J Taylor; C Zollikofer; W W Klein; B Mulder; L A Providencia
Journal:  Eur Heart J       Date:  2001-09       Impact factor: 29.983

Review 2.  Has the mortality of septic shock changed with time.

Authors:  G Friedman; E Silva; J L Vincent
Journal:  Crit Care Med       Date:  1998-12       Impact factor: 7.598

3.  Efficacy and safety of recombinant human activated protein C for severe sepsis.

Authors:  G R Bernard; J L Vincent; P F Laterre; S P LaRosa; J F Dhainaut; A Lopez-Rodriguez; J S Steingrub; G E Garber; J D Helterbrand; E W Ely; C J Fisher
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

Review 4.  Arginine vasopressin in 316 patients with advanced vasodilatory shock.

Authors:  Günter Luckner; Martin W Dünser; Stefan Jochberger; Viktoria D Mayr; Volker Wenzel; Hanno Ulmer; Stefan Schmid; Hans Knotzer; Werner Pajk; Walter Hasibeder; Andreas J Mayr; Barbara Friesenecker
Journal:  Crit Care Med       Date:  2005-11       Impact factor: 7.598

Review 5.  [Shock].

Authors:  U Janssens; P Hanrath
Journal:  Internist (Berl)       Date:  1994-07       Impact factor: 0.743

6.  Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death.

Authors:  Edward Abraham; Pierre-François Laterre; Rekha Garg; Howard Levy; Deepak Talwar; Benjamin L Trzaskoma; Bruno François; Jeffrey S Guy; Martina Brückmann; Alvaro Rea-Neto; Rolf Rossaint; Dominique Perrotin; Armin Sablotzki; Nancy Arkins; Barbara G Utterback; William L Macias
Journal:  N Engl J Med       Date:  2005-09-29       Impact factor: 91.245

7.  Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials.

Authors:  M M Wilkes; R J Navickis
Journal:  Ann Intern Med       Date:  2001-08-07       Impact factor: 25.391

Review 8.  Timing and volume of fluid administration for patients with bleeding.

Authors:  I Kwan; F Bunn; I Roberts
Journal:  Cochrane Database Syst Rev       Date:  2003

Review 9.  [Volume replacement with hydroxyethyl starch: is there an influence on kidney function?].

Authors:  S Suttner; J Boldt
Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther       Date:  2004-02       Impact factor: 0.698

Review 10.  Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.

Authors:  R Phillip Dellinger; Jean M Carlet; Henry Masur; Herwig Gerlach; Thierry Calandra; Jonathan Cohen; Juan Gea-Banacloche; Didier Keh; John C Marshall; Margaret M Parker; Graham Ramsay; Janice L Zimmerman; Jean-Louis Vincent; Mitchell M Levy
Journal:  Crit Care Med       Date:  2004-03       Impact factor: 7.598

View more
  1 in total

Review 1.  [Hemorrhagic shock : General principles].

Authors:  T I Eiben; V Fuhrmann; B Saugel; S Kluge
Journal:  Internist (Berl)       Date:  2017-03       Impact factor: 0.743

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.